Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
Pfizer's Xtandi fails in progression trial vs J&J's Zytiga
Yahoo/Reuters
Thu, 12/15/16 - 10:10 am
Tags:
Xtandi
,
Pfizer
,
JNJ
,
Zytiga
,
prostate cancer
Actelion Would Be Second-Best Solution For Sanofi
Forbes
Wed, 12/14/16 - 09:22 am
Tags:
Actelion
,
JNJ
,
Sanofi
,
M&A
Sanofi Said to Hold Talks With Actelion After J&J Walks Away
Bloomberg
Wed, 12/14/16 - 09:22 am
Tags:
Sanofi
,
JNJ
,
Actelion
,
M&A
Actelion Shares Plunge After J&J Drops Potential $27 Billion Takeover
TheStreet.com
Wed, 12/14/16 - 09:21 am
Tags:
Actelion
,
JNJ
,
M&A
,
Sanofi
Johnson & Johnson’s Pharmaceuticals Segment in 3Q16
Market Realist
Mon, 12/12/16 - 09:32 am
Tags:
JNJ
Standing Up To The Test Of Time: Two Cancer Drugs That Could Survive A Hobbled FDA
Forbes
Thu, 12/8/16 - 09:59 am
Tags:
FDA
,
Seattle Genetics
,
Takeda
,
Adcetris
,
Hodgkin's lymphoma
,
AbbVie
,
JNJ
,
Ibruvica
,
mantle cell lymphoma
Will Johnson & Johnson Take Over Actelion?
Investopedia
Wed, 12/7/16 - 07:47 pm
Tags:
JNJ
,
Actelion
,
M&A
,
Sanofi
Sanofi and Johnson & Johnson May Battle for the Right to Overpay for Actelion
Motley Fool
Wed, 12/7/16 - 10:44 am
Tags:
JNJ
,
Sanofi
,
Actelion
,
M&A
Top Actelion shareholder says backs J&J deal above 246 Sfr/share
Yahoo/Reuters
Tue, 12/6/16 - 09:54 am
Tags:
Actelion
,
JNJ
,
M&A
J&J Woos Billionaire Doctors Who Don’t Need Cash in Actelion Bid
Bloomberg
Tue, 12/6/16 - 09:52 am
Tags:
JNJ
,
physicians
,
Actelion
,
M&A
Sanofi to Explore Counterbid for Actelion Amid J&J Talks
Bloomberg
Mon, 12/5/16 - 11:13 pm
Tags:
Sanofi
,
Actelion
,
JNJ
,
M&A
J&J's $26 Billion Swiss Drugs Experiment
Bloomberg
Mon, 12/5/16 - 10:07 am
Tags:
JNJ
,
Switzerland
,
Actelion
,
M&A
,
PAH
J&J Plans to Appeal Staggering $1B Judgment Against Hip Implant
TheStreet.com
Sun, 12/4/16 - 12:29 pm
Tags:
JNJ
,
hip implants
J&J’s Raised Offer for Actelion Said North of $250 a Share
Bloomberg
Sat, 12/3/16 - 12:06 am
Tags:
JNJ
,
M&A
,
Actelion
Intuitive Surgical, J&J’s Ethicon bury the hatchet over sales rep’s non-compete
Mass Device
Fri, 12/2/16 - 11:25 am
Tags:
JNJ
,
Ethicon
,
Intuitive Surgical
,
non-compete
,
devices
Johnson & Johnson Throws Caution to the Wind With a Large Bid for Actelion
Motley Fool
Wed, 11/30/16 - 10:07 am
Tags:
JNJ
,
Actelion
,
M&A
J&J Raises Takeover Offer for Europe's Largest Biotech Firm Actelion
Bloomberg
Wed, 11/30/16 - 10:06 am
Tags:
JNJ
,
Actelion
,
M&A
Actelion Shares Fall Sharply on Report It Is Resisting $17 Billion J&J Takeover
TheStreet.com
Tue, 11/29/16 - 09:56 am
Tags:
Actelion
,
JNJ
,
M&A
J&J confirms it is in talks to buy Swiss biotech Actelion
Endpoints
Sun, 11/27/16 - 03:57 pm
Tags:
JNJ
,
Actelion
,
M&A
JNJ's Expensive Leukemia Drug Wins British Nod
Investopedia
Sun, 11/27/16 - 03:54 pm
Tags:
JNJ
,
UK
,
Imbruvica
,
chronic lymphocytic leukemia
,
CLL
Pages
« first
‹ previous
…
79
80
81
82
83
84
85
86
87
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.